204 related articles for article (PubMed ID: 37945124)
1. Carbapenem-resistant Klebsiella pneumoniae outbreak with monoclonal spread: Evaluation of resistance genes and ceftazidime-avibactam susceptibility.
Arıcı N; Tanrıverdi ES; Çalık Ş; Kansak N; Adaleti R; Otlu B; Aksaray S
Indian J Med Microbiol; 2023; 46():100431. PubMed ID: 37945124
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
Zornic S; Petrovic I; Lukovic B
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
[TBL] [Abstract][Full Text] [Related]
3. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant
Zhang WX; Chen HY; Chen C; Chen JH; Wan FS; Li LX; Chen M; Zhang J
Microb Drug Resist; 2021 Oct; 27(10):1312-1318. PubMed ID: 34297609
[No Abstract] [Full Text] [Related]
4. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis.
Krithika VM; Ganesan V; Rajendran T
Indian J Med Microbiol; 2024; 49():100603. PubMed ID: 38705276
[TBL] [Abstract][Full Text] [Related]
5. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
6. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
7. Performance of Carbapenemase Nordmann-Poirel, Modified Carbapenem Inactivation, and EDTA Carbapenem Inactivation Methods for Detecting Carbapenem-Resistant
Sarva K; Marimuthu Ragavan R; Tadi LJ; Raja S; Narasingam A
Microb Drug Resist; 2023 Nov; 29(11):504-509. PubMed ID: 37729073
[TBL] [Abstract][Full Text] [Related]
8. Evaluating molecular epidemiology of carbapenem non-susceptible Klebsiella pneumoniae isolates with MLST, MALDI-TOF MS, PFGE.
Ibik YE; Ejder N; Sevim E; Rakici E; Tanriverdi ES; Copur Cicek A
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):93. PubMed ID: 37891628
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey.
Genç S; Kolaylı F; Özçelik EY
J Infect Chemother; 2022 Feb; 28(2):192-198. PubMed ID: 34711509
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression and Amplification of
Li X; Zhang J; Yang C; Li J; Wang J; Huang W; Zeng L; Liang X; Long W; Zhang X
Microbiol Spectr; 2022 Aug; 10(4):e0095522. PubMed ID: 35900090
[TBL] [Abstract][Full Text] [Related]
11. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M
J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313
[TBL] [Abstract][Full Text] [Related]
12. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.
Laolerd W; Akeda Y; Preeyanon L; Ratthawongjirakul P; Santanirand P
Microb Drug Resist; 2018 Sep; 24(7):1006-1011. PubMed ID: 29782216
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
Tekintaş Y; Çilli F; Eraç B; Yaşar M; Aydemir SŞ; Hoşgör Limoncu M
Mikrobiyol Bul; 2017 Jul; 51(3):269-276. PubMed ID: 28929963
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
16. [Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina].
Pellegrini JL; Aguirre C; Soto SM; Lovera LMR; Lösch LS; Conza JAD; Merino LA
Rev Chilena Infectol; 2022 Apr; 39(2):109-116. PubMed ID: 35856982
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem antibiotic stress increases bla
Chen H; Li N; Wang F; Wang L; Liang W
J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
[TBL] [Abstract][Full Text] [Related]
18. The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant
Nasomsong W; Nulsopapon P; Changpradub D; Pongchaidecha M; Pungcharoenkijkul S; Juntanawiwat P; Simsiriporn W; Santimaleeworagun W
Drug Des Devel Ther; 2021; 15():3095-3104. PubMed ID: 34295150
[TBL] [Abstract][Full Text] [Related]
19. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in
Giddins MJ; Macesic N; Annavajhala MK; Stump S; Khan S; McConville TH; Mehta M; Gomez-Simmonds A; Uhlemann AC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263067
[TBL] [Abstract][Full Text] [Related]
20. Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran.
Jafari Z; Harati AA; Haeili M; Kardan-Yamchi J; Jafari S; Jabalameli F; Meysamie A; Abdollahi A; Feizabadi MM
Microb Drug Resist; 2019 Apr; 25(3):336-343. PubMed ID: 30351186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]